Article Versions Notes

Aljobaily N, Krutsinger K, Viereckl MJ, Joly R, Menlove B, Cone B, Suppes A, Han Y. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor. Nutrients. 2023; 15(1):178. https://doi.org/10.3390/nu15010178

Aljobaily, Nouf, Kelsey Krutsinger, Michael J. Viereckl, Raznin Joly, Bridger Menlove, Brexton Cone, Ailaina Suppes, and Yuyan Han. 2023. "Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor" Nutrients 15, no. 1: 178. https://doi.org/10.3390/nu15010178

Aljobaily, N., Krutsinger, K., Viereckl, M. J., Joly, R., Menlove, B., Cone, B., Suppes, A., & Han, Y. (2023). Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor. Nutrients, 15(1), 178. https://doi.org/10.3390/nu15010178